1
/
of
1
NANO - KLOW + 3ml BAC Water
NANO - KLOW + 3ml BAC Water
Regular price
R 1,100.00 ZAR
Regular price
Sale price
R 1,100.00 ZAR
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Component concentrations: TB-500, BPC-157, KPV each at ~3.33 mg/mL; GHK-Cu at ~16.7 mg/mL.
| Week | Daily Dose (per component) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | TB-500: 250 mcg | BPC-157: 250 mcg | KPV: 250 mcg | GHK-Cu: 1.25 mg | 7.5 units (0.075 mL) |
| Weeks 3–4 | TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg | 15 units (0.15 mL) |
| Weeks 5–8 | TB-500: 750 mcg | BPC-157: 750 mcg | KPV: 750 mcg | GHK-Cu: 3.75 mg | 22.5 units (0.225 mL) |
| Weeks 9–12 (Maintenance) | TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg | 15 units (0.15 mL) |
Dosing Protocol
Suggested daily titration approach.
- Start: 7.5 units daily (0.075 mL) for initial assessment period.
- Increase: Progress to 15 units by Week 3, then 22.5 units by Week 5 as tolerated.
- Maintenance: 15 units daily for extended protocols.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks.
- Timing: Any consistent time; rotate injection sites.
Share
